DIAGNOSTIC CRITERIA FOR  JOINT

HYPERMOBILITY SYNDROME (JHS)

Recently diagnosing the JHS has been eased with the newly revised Diagnostic Criteria.  It has been detected that the Beighton Score, used for 30 years, was insufficient, since it only considered a few joints and not the complications caused by tissue fragility.  The Brighton Criteria includes and extends the old Beighton Score, which now makes the Joint Hypermobility Syndrome (JHS) diagnosis much more precise.  This is due to the fact that many patients with this syndrome have only a few hypermobile joints or have some joints not comprised by this method, thus it became necessary to widen the criteria.  Besides having hypermobile joints, JHS can present several symptoms which compromise other tissues, such as skin alterations (soft, thin, lax, translucent that shows the veins, bruises, striae, poor wound healing), hernias, uterine and/or rectal prolapse, varicose veins, mitral valve prolapse, myopia, etc.  This group also includes Marfanoide habitus (tall, thin, with long arms and fingers). In patients with JHS there is not only fragility of the tendons but also alterations of other tissues and organs due to the genetic alteration of the collagen fiber. It is necessary to be very well acquainted with these criteria for the diagnosis of these conditions.  For a precise diagnosis it is necessary to, first, determine the Beighton Score followed by the Brighton Criteria. It is very unfortunate that these two names are so similar, reason for which they are usually confused.

Other Criteria, such as the Vascular Ehlers-Danlos (EDS-IV) and Marfan Syndrome, are included for the diagnosis of these Hereditary Diseases of Connective Tissue (HDCT).

 

Beighton Score

 

Helps to determine the degree of joint hypermobility.  Currently it is used as part of the Brighton Criteria.  For a positive Beighton Score, 4 or more points out of nine are required (i.e. two elbows and two hypermobile knees):

 

1.      More than 10º hyperextension of the elbows

2.      Passively touch the forearm with the thumb, while flexing the wrist.

3.      Passive extension of the fingers or a 90º or more extension of the fifth finger (Gorling’s sign).  This is used as a “Screen Test”.

4.      Knees hyperextension greater than or equal to 10º (genu-recurvatum)

5.      Touching the floor with the palms of the hands when reaching down without bending the knees.   This is possible as a result of the hypermobility of the hips, and not of the spine as it is commonly believed

 

Reference:  

 

Beighton PH, Solomon L, Soskolone CL.  Articular mobility in an African population.  Am. Rheum. Dis.1973; 32 : 413-18.

 

 

Brighton Criteria for the Diagnosis of JHS

Major Criteria

·         A Beighton score of 4/9 or greater (either currently or historically)

·         Arthralgia for longer than 3 months in 4 or more joints

Minor Criteria

·         A Beighton score of 1, 2 or 3/9 (0, 1, 2 or 3 if aged 50+)

·         Arthralgia (> 3 months) in one to three joints or back pain (> 3 months), spondylosis, spondylolysis/spondylolisthesis.

·         Dislocation/subluxation in more than one joint, or in one joint on more than one occasion.

·         Soft tissue rheumatism. > 3 lesions (e.g. epicondylitis, tenosynovitis, bursitis).

·         Marfanoid habitus (tall, slim, span/height ratio >1.03, upper: lower segment ratio less than 0.89, arachnodactily [positive Steinberg/wrist signs]).

·         Abnormal skin: striae, hyperextensibility, thin skin, papyraceous scarring.

·         Eye signs: drooping eyelids or myopia or antimongoloid slant.

·         Varicose veins or hernia or uterine/rectal prolapse.

The Joint Hypermobility Syndrome (JHS) is diagnosed in the presence two major criteria, or one major and two minor criteria, or four minor criteria. Two minor criteria will suffice where there is an unequivocally affected first-degree relative.

JHS is excluded by presence of Marfan or Ehlers-Danlos syndromes (other than the EDS Hypermobility type (formerly EDS III) as defined by the Ghent 1986 and the Villefranche 1998 criteria respectively).

 

Criteria Major 1 and Minor 1 are mutually exclusive as are Major 2 and Minor 2.

 

Note:   It is necessary for Rheumatologists and Traumatologists to be well acquainted with these criteria and to use them routinely, when examining their patients.  I suggest keeping a copy of this document at hand, as well as the criteria for other HDCT described below, since this is the only way to make a correct diagnosis. 

 

 

 a) Typical JHS facial appearance:

 

·         Blue sclera, especially seen in females.

·         Atypical ears: prominent “winged”, small, round, lobeless,  lobe attached to face, ears with different shapes: kidney shape, “Dumbo ears”, “Mr. Spock ears”, soft ears, with bent helix.

 

·         Abnormal nose: with a lump in the union of the bone and the cartilage, nasal  septum  deviation,  soft  nostrils  or already operated nose.

·         Some patients may have a prominent chin (triangular face).

 

Note:  This facial appearance was first described by Jaime F. Bravo, MD in Reumatologia 2004;20(1):24-30

 

 

 

 

b) Marfanoid habitus, in both sexes, was seen in 14% of our patients and reported in 30% in Grahame series. They usually have arachnodactily and long and narrow feet (big shoe sizes). They may have mild pectum excavatum and prominent lower ribs.

 

     

 

c) Hyperflexion of more than 90° of the metacarpo-phalangeal joints or wrists or marked hyperextension of the fingers, when patients hold their head with their hand, during the interview.

 

 

References:

Grahame R, Bird HA, Child A et al.  The British Society for Rheumatology Special Interest Group on Heritable Disorders of Connective Tissue criteria for the benign joint hypermobility syndrome.  The revised (Brighton 1998) criteria for the diagnosis of BJHS.  J Rheumatol 2000; 27: 1777-79.

Beighton P, DePaepe A, Danks D, et al.  International Nosology of Heritable Disorders of Connective Tissue, Berlin 1986. Am J Med Genet 1988;29:581-94.

Beighton P,  DePaepe A,  Steinmann B,  Tsipouras P  and  Wenstrup RJ.  Ehlers-Danlos Syndromes: Revised Nosology, Villefranche, 1977.  Am J Med Gen 1998; 77: 31-37

Bravo, J F.   Síndrome de Hipermovilidad Articular. Como diferenciarlo de las otras Alteraciones Hereditarias de la  Fibra Colágena.  Reumatologia 2004;20(1):24-30   

 

 

 

Diagnostic Criteria for Vascular Ehlers-Danlos Syndrome

(EDS- IV)

 

 

Major criteria

 

-         Thin, translucent skin (especially noticeable on the chest/abdomen)

-         Arterial rupture, Intestinal rupture, Uterine rupture during pregnancy

-         Easy bruising (spontaneous or with minimal trauma)

-         Characteristic facial appearance (thin lips and philtrum, small chin, thin nose, large eyes)

 

The presence of one or more minor criteria contribute to the diagnosis of the vascular type of EDS, but are not sufficient to establish the diagnosis, biochemical testing is strongly recommended to confirm the diagnosis.

 

Minor criteria:

 

-         Acrogeria (an aged appearance to the extremities, particularly the hands)

-         Hypermobility of small joints

-         Tendon/muscle rupture

-         Talipes equinovarus (clubfoot)

-         Early-onset varicose veins

-         Arteriovenous carotid-cavernous sinus fistula

-         Pneumothorax/pneumohemothorax

-         Gingival recession

-         Family history of the vascular type of EDS

 

Generally these patients are not very mobile , except for only hypermobile fingers.

 

Reference:

 

Beighton P,  DePaepe A,  Steinmann B,  Tsipouras P  and  Wenstrup RJ.  Ehlers-Danlos Syndromes: Revised Nosology,  Villefranche, 1977.  Am J Med Gen 1998; 77: 31-37

 

 

Diagnostic Criteria for Marfan Syndrome

 

This criteria is based on clinical findings in the various organ systems, and in the nature of the family history and relationships. A "major" criterion is one that carries high diagnostic specificity, because it is relatively infrequent in other conditions and in the general population. A nuance in this revision is the conversion of a number of minor criteria in the skeletal system into a major criterion.

There is an important distinction between a major criterion being present in a system, and the system "being involved". The latter, while important in the diagnostic decision matrix, is less important than having an evident major criterion.

 

Photo taken from the literature

Skeletal System

Major criterion. Presence of at least 4 of the following manifestations.

-         pectus carinatum

-         pectus excavatum requiring surgery

-         reduced upper to lower segment ratio or arm span to height ratio greater than 1.05

-         wrist and thumb signs

-         scoliosis of greater than 20° or spondylolisthesis

-         reduced extension at the elbows (< 170°)

-         medial displacement of the medial malleolus causing pes planus

-          protrusio acetabulae of any degree (ascertained on radiographs)

Minor criteria.

-         pectus excavatum of moderate severity

-         joint hypermobility

-         highly arched palate with crowding of teeth

-          facial appearance (dolichocephaly, malar hypoplasia, enophthalmos, retrognathia, down-Slanting palpebral fissures)

For the skeletal system to be considered involved, at least 2 of the components comprising the major criterion or one component comprising the major criterion plus 2 of the minor criteria must be present.

Ocular System

Major criterion.

-          ectopia lentis

Minor criteria.

-         abnormally flat cornea (as measured by keratometry)

-         increased axial length of globe (as measured by ultrasound)

-          hypoplastic iris or hypoplastic ciliary muscle causing decreased miosis

Cardiovascular System

Major criteria.

-         dilatation of the ascending aorta with or without aortic regurgitation and involving at least the sinuses of Valsalva; or

-          dissection of the ascending aorta

Minor criteria.

-         mitral valve prolapse with or without mitral valve regurgitation;

-         dilatation of the main pulmonary artery, in the absence of valvular or peripheral pulmonic stenosis or any other obvious cause, below the age of 40 years;

-         calcification of the mitral annulus below the age of 40 years; or

-         dilatation or dissection of the descending thoracic or abdominal aorta below the age of 50 years

-         For the cardiovascular system to be involved a major criterion or only one of the minor criteria must be present.

 Pulmonary System

Major criteria.

-          none

Minor criteria.

-         spontaneous pneumothorax [Hall et al., 1984], or

-          apical blebs (ascertained by chest radiography)

Skin and Integument

Major criterion.

-          none

Minor criteria.

-         striae atrophicae (stretch marks) not associated with marked weight changes, pregnancy or repetitive stress, or

-          recurrent or incisional herniae

For the skin and integument to be involved one of the minor criteria must be present.

 

Dura

Major criterion

-          lumbosacral dural ectasia by CT or MRI

Minor criteria

-          None

For the dura to be involved the major criterion must be present.

 Family/Genetic History

Major criteria.

-         having a parent, child or sib who meets these diagnostic criteria independently;

-         presence of a mutation in FBN1 known to cause the Marfan syndrome; or

-          presence of a haplotype around FBN1, inherited by descent, known to be associated with unequivocally diagnosed Marfan syndrome in the family

Minor criteria.

-          None

For the family/genetic history to be contributory, one of the major criteria must be present.

Requirements of the Diagnosis of the Marfan Syndrome

For the index case:

-         If the family/genetic history is not contributory, major criteria in at least 2 different organ systems and involvement of a third organ system

-          If a mutation known to cause Marfan syndrome in others is detected, one major criterion in an organ system and involvement of a second organ system

For a relative of an index case:

-         presence of a major criterion in the family history and one major criterion in an organ system and involvement of a second organ system

 

 

Reference:

 

DePaepe A, Devereux RB, Dietz H, et al. Revised diagnostic criteria for the Marfan Syndrome. Am J Med Genet 1996, 62: 417-426.

 

 

                                                                                                        Jaime F Bravo MD

                                                                                                   Rheumatology-Osteoporosis

                                                                                                 

Revised:  November 22nd , 2004